Cleveland v. Ludwig Institute for Cancer Research Ltd

District Court, S.D. California·Decided February 8, 2022·No. 3:19-cv-02141·Unknown

Opinion

1 2 3 4 5 6 7 8 UNITED STATES DISTRICT COURT 9 SOUTHERN DISTRICT OF CALIFORNIA 10 11 DON CLEVELAND, et al., Case No.: 19-cv-02141-JM-JLB

12 Plaintiffs, ORDER GRANTING 13 v. PLAINTIFFS/COUNTER- DEFENDANTS MOTION TO DE- 14 LUDWIG INSTITUTE FOR CANCER DESIGNATE ONE PORTION OF RESEARCH LTD, et al., 15 ONE DOCUMENT Defendants. 16 [ECF Nos. 111, 112] 17 AND RELATED COUNTERCLAIM. 18 19 20 Before the Court is a Motion to De-Designate One Portion of One Document filed 21 by Plaintiffs/Counter-Defendants Don Cleveland, Arshad Desai, Frank Furnari, Richard 22 Kolodner, Paul Mischel, Karen Oegema and Bing Ren (collectively, “Plaintiffs”). (ECF 23 Nos. 111, 112.) Plaintiffs seek to de-designate one portion of one document 24 (LUDWIG0001443), specifically the statement that “overall the Branch is being seen as 25 post-mature.” (ECF No. 111-1 at 2.) 26 Defendants Ludwig Institute for Cancer Research Ltd. (the “Institute” or “Ludwig”), 27 Chi Van Dang, Edward A. McDermott, Jr., and John L. Notter (collectively, “Defendants”) 28 filed an opposition. (ECF No. 116.) Plaintiffs filed a reply. (ECF No. 117.) Upon review 1 of the motion, the opposition, the reply, and all supporting documents, the Court GRANTS 2 the Motion to De-Designate. 3 I. BACKGROUND 4 A. Ludwig I 5 On November 7, 2019, Plaintiffs commenced the above-captioned action, 6 Cleveland, et al. v. Ludwig Institute for Cancer Research Ltd, et al., Case No. 19-cv-02141- 7 JM-JLB (S.D. Cal.) (“Ludwig I”). (ECF No. 1.) On July 8, 2020, Plaintiffs filed a Second 8 Amended Complaint (“SAC”), the operative complaint. (ECF No. 26.) 9 According to the SAC, Plaintiffs are internationally acclaimed cancer research 10 scientists and physicians. (SAC ¶ 1.) Ludwig is an international nonprofit organization 11 dedicated to finding a cure for cancer that operates multiple cancer research branches. (Id. 12 ¶¶ 1, 142.) In 1991, Ludwig entered into an “Affiliation Agreement” (“the AA”) with the 13 University of California at San Diego (“UCSD”) to establish a San Diego Branch (“the 14 Branch”). (Id. ¶ 51.) Ludwig agreed to conduct “active” and “continuous” medical 15 research to “discover, develop, or verify knowledge related to causes, diagnoses, treatment, 16 prevention and control of cancer.” (Id. ¶ 53.) Ludwig also agreed to “bear the costs directly 17 related to conducting the research program.” (Id. ¶ 62.) The term of the AA is coterminous 18 with a lease agreement for research facilities between Ludwig and UCSD, which allows 19 Ludwig to terminate the lease no earlier than December 31, 2023. (Id. ¶¶ 4, 16, 56.) In 20 addition to leasing its facilities to Ludwig, UCSD agreed to: (1) grant privileges for the 21 practice of medicine at its hospital to qualified members of the medical staff at the Branch; 22 (2) grant “academic recognition and titles” to qualified Ludwig employees; and (3) make 23 full time equivalency positions available for Ludwig employees. (Id. ¶ 154.) 24 Between 1996 and 2016, Ludwig hired Plaintiffs to work at the Branch. (Id. ¶¶ 26– 25 32.) In 2018, Ludwig announced that it would “cease funding the Branch and otherwise 26 halt the ‘continuous active conduct of medical research’ at the Branch.” (Id. ¶ 15.) 27 Effective January 1, 2020, Ludwig “terminated all funding for Plaintiffs’ laboratories.” (Id. 28 ¶ 18.) However, “Ludwig continues to fund at least part of the rent due [to UCSD] and it 1 continues to pay the Plaintiffs’ own salaries and benefits, but nothing more.” (Id.) As a 2 result, Plaintiffs’ “[l]aboratories and ongoing translational research programs have ceased 3 or substantially curtailed ongoing research projects, except to the extent that they have 4 access to outside grants.” (Id.) 5 In their SAC, Plaintiffs asserted the following claims against Ludwig: (1) breach of 6 the AA; (2) breach of Plaintiffs’ Intellectual Property (“IP”) agreements; (3) breach of 7 Plaintiffs’ lab contracts; (4) breach of the implied covenant of good faith and fair dealing; 8 (5) promissory estoppel under the AA; (5) declaratory relief; and (6) false light. (SAC ¶¶ 9 145–70, 182–303.) Plaintiffs also bring a claim against all Defendants for defamation per 10 se. (Id. ¶¶ 171–81.) On November 25, 2020, the Honorable Jeffrey T. Miller dismissed 11 Plaintiffs’ claims for breach of the AA and breach of Plaintiffs’ IP agreements. (ECF No. 12 32 at 28.) He also dismissed Plaintiffs’ declaratory relief claim with respect to Plaintiffs’ 13 claims based on the AA and IP agreements, and their claim for breach of the implied 14 covenant in the AA and lab contracts. (Id.) 15 B. Ludwig II 16 On May 5, 2021, Plaintiffs filed a separate lawsuit against Ludwig: Cleveland, et al. 17 v. Ludwig Institute for Cancer Research Ltd., Case No. 21-cv-00871-JM-JLB (S.D. Cal.) 18 (“Ludwig II”). (Ludwig II, ECF No. 1.) In Ludwig II, Plaintiffs bring claims against 19 Ludwig for: (1) retaliation in violation of California Government Code § 12940(h); (2) age 20 discrimination under the Fair Employment and Housing Act (“FEHA”); (3) wrongful 21 adverse employment action in violation of public policy; (4) failure to timely pay wages; 22 and (5) violation of California’s unfair competition laws. (Id. at 13–21.) Kolodner also 23 brings a separate claim for retaliation in violation of California Labor Code § 1102.5. (Id. 24 at 12–13.) 25 On May 12, 2021, Ludwig II was low number transferred to Judge Miller and the 26 undersigned judge for all further proceedings. (Ludwig II, ECF No. 4.) On July 2, 2021, 27 Judge Miller denied Plaintiffs’ motion to consolidate Ludwig I and Ludwig II. (Ludwig II, 28 ECF No. 13.) On July 6, 2021, Ludwig filed a motion to dismiss all claims in the Ludwig II 1 complaint pursuant to Federal Rule of Civil Procedure 12(b)(6). (Id., ECF No. 14.) On 2 January 7, 2022, Judge Miller granted in part and denied in part Ludwig’s motion to 3 dismiss. (Id., ECF No. 18.) As pertinent here, Judge Miller granted Ludwig’s motion to 4 dismiss Plaintiff’s age discrimination claim under FEHA, with leave to amend. (Id.) 5 C. Protective Order 6 On February 19, 2021, the parties filed a joint motion for entry of stipulated 7 protective order in Ludwig I. (ECF No. 44.) The proposed protective order was largely 8 based on the Southern District of California’s model protective order, which is available 9 on the district court’s website. The proposed protective order also contained the 10 undersigned judge’s required language, as set forth in her Civil Chambers Rules. See J. 11 Burkhardt Civ. Chambers R. § VI.B. On February 22, 2021, the Court granted the joint 12 motion and entered the parties’ stipulated protective order (“Protective Order”). (ECF No. 13 45.) 14 D. April 2018 Minutes 15 On January 14, 2020, Ludwig initially produced the minutes of an April 24, 2018 16 meeting of Ludwig’s Board of Directors (the “April 2018 Minutes”), with the designation 17 of “Outside Counsel Eyes Only.” (ECF No. 105 at 8–9.) At Plaintiffs’ request, Defendants 18 reproduced the April 2018 Minutes with a reduced “Confidential” designation on 19 March 8, 2021. (Id. at 9.) The April 2018 Minutes contain the statement that “overall the 20 Branch is being seen as post-mature.” (ECF No. 111-1 at 2.) 21 On May 5, 2021, Plaintiffs commenced Ludwig II and referenced, as well as quoted 22 from, the April 2018 Minutes in their Complaint. (Ludwig II, ECF No. 1.) Specifically, 23 Plaintiffs stated the following in their Complaint under “General Allegations”: 24 Plaintiffs Kolodner and Cleveland first began their work at the Branch 25 in 1997 and 1995, respectively and have been closely identified with the Branch and have led its efforts for decades. Plaintiffs Kolodner and Cleveland 26 were each more than 40 years old at all times in 2018 and later. The Board 27 of Ludwig made a decision to close the Branch at a meeting held in April 2018.

Free access — add to your briefcase to read the full text and ask questions with AI

Cleveland v. Ludwig Institute for Cancer Research Ltd, (S.D. Cal. 2022).

Cleveland v. Ludwig Institute for Cancer Research Ltd (Cleveland v. Ludwig Institute for Cancer Research Ltd) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

In Re Roman Catholic Archbishop of Portland in Or.
661 F.3d 417 (Ninth Circuit, 2011)
Phillips v. General Motors Corporation
307 F.3d 1206 (Ninth Circuit, 2002)
In Re Gilead Sciences Securities Litigation
536 F.3d 1049 (Ninth Circuit, 2008)
Guz v. Bechtel National, Inc.
8 P.3d 1089 (California Supreme Court, 2000)
Cipollone v. Liggett Group, Inc.
785 F.2d 1108 (Third Circuit, 1986)
Littlejohn v. BIC Corp.
851 F.2d 673 (Third Circuit, 1988)